{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-26-059699","form_type":"8-K","ticker":"MMED","cik":"0002062583","company_name":"MiniMed Group, Inc.","filed_at":"2026-09-01T10:50:10+00:00","discovered_at":"2026-09-01T10:55:04.535160+00:00","generated_at":"2026-09-01T10:55:09.822190+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"MiniMed Q1 FY27 net sales $843M +16.6%; raises FY27 organic growth to ~10.5%","bullets":["Net sales $843M, +16.6% as reported, +15.8% organic; U.S. +13.1% to $240M, international +18.1% to $603M.","Worldwide NPS ~34,000 (+7.7% YoY); CGM attachment rate 69% (+~100bps QoQ).","Raises FY27 organic revenue growth to ~10.5% (from ~10%); reaffirms adjusted EBITDA margin ~16%.","Pipeline: MiniMed Fit FDA submission ahead of Fall; Flex CE Mark; Vivera pivotal enrollment complete; next-gen sensor IDE approved.","U.S. launch of MiniMed Flex with Instinct started Aug 17; Medicare coverage expanded."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-26-059699","json":"https://secwatch.observer/filing/0001628280-26-059699.json","markdown":"https://secwatch.observer/filing/0001628280-26-059699.md","text":"https://secwatch.observer/filing/0001628280-26-059699.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/2062583/000162828026059699/0001628280-26-059699-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2062583/000162828026059699/mmed-20260901.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-09-01T10:55:09.822190+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}